Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA906: Rimegepant for preventing episodic migraine |
|
Medicine details |
|
Medicine name | rimepagent (Vydura®) |
Formulation | oral |
Reference number | 5281 |
Indication | For preventing episodic migraine |
Company | Pfizer Ltd |
BNF chapter | Central nervous system |
Submission type | N/A |
Status | Excluded due to NICE appraisal |
Date of issue | 31/05/2023 |
NICE guidance |